Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2007
11/13/2007US7294753 Method for preparing anti-MIF antibodies
11/13/2007US7294720 N3-(hydroxy- or alkoxyphenyl) amidrazone, e.g., N3-[3-Methoxyphenyl]-p-tert-butyl-benzamidrazone, are intermediates for preparing phenyl-1,2,4-triazoles, e.g., 1-{3-[4-(tert-Butyl)phenyl]-(1,2,4-triazol-4-yl)}-3-methoxybenzene
11/13/2007US7294652 Autoimmune conditions and NADPH oxidase defects
11/13/2007US7294634 Controlling cell proliferation; anticancer agents
11/13/2007US7294628 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
11/13/2007US7294625 Pyrazole compounds
11/13/2007US7294624 Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases
11/13/2007US7294618 Glucopyranosyloxypyrazole derivatives and medicinal use thereof
11/13/2007US7294480 High throughput screening assays using fatty acid synthetic enzymes
11/13/2007US7294472 Method for identifying modulators of G protein coupled receptor signaling
11/13/2007CA2342804C Vending machine
11/09/2007CA2589295A1 Characterization of c19orf10, a novel synovial protein
11/08/2007WO2007125197A1 Novel imidazole derivatives, preparation and user thereof as medicine
11/08/2007WO2007092095A3 [4-(benzo [b] thi0phen-2-yl) pyrimidin-2yl] -amine derivatives as ikk-beta inhibitors for the treatment of cancer and inflammatory diseases.
11/08/2007WO2007062877A3 PRODRUG ERβ-SELECTIVE SUBSTANCES, METHODS FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS
11/08/2007WO2006110883A8 Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
11/08/2007US20070259958 Prevention of Neutrophil Recruitment
11/08/2007US20070259918 2-Hydroxymethyl-3,4,5-Trihydroxy-1-(4-Pentyloxybenzyl) Piperidine as Glucosylceramide Synthase (Gcs) Inhibitor
11/08/2007US20070259904 Bi-aryl meta-pyrimidine inhibitors of kinases
11/08/2007US20070259892 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres
11/08/2007US20070259887 Inhibitors of polyq-aggregation
11/08/2007US20070259882 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
11/08/2007US20070259874 Phosphodiesterase Inhibitors
11/08/2007US20070259873 Selective in presence of at least one other cathepsin isozyme; such as N-{-2-[2-(4-methoxy-phenylamino)-ethylcarbamoyl]-cyclohexyl}-3-methyl-benzamide
11/08/2007US20070259856 Method for Activating Trpv4 Channel Receptors by Agonists
11/08/2007US20070259855 Thiazolyl-dihydro-indazole
11/08/2007US20070259838 17,20(Z)-Dehydro Vitamin D Analogs and Their Uses
11/08/2007US20070259816 Expression vector comprising nucleotide sequences coding homeobox gene for use in identifying modulators for treatment and prevention of nervous system and seizure disorders
11/08/2007US20070259815 Albumin fusion proteins
11/08/2007US20070259814 Platelet Derived Growth Factor and Methods of Use Thereof
11/08/2007US20070258982 Methods of using antibodies against human IL-22
11/08/2007US20070258980 Vascular endothelial cell growth factor antagonists and uses thereof
11/08/2007US20070258974 Diagnostics and Therapeutics for Diseases Associated with Puromycin Sensitive Aminopeptidase Npepps (Npepps)
11/08/2007DE60021370C5 Piperazinderivate verwendbar als ccr5 antagonisten Piperazine derivatives useful as antagonists ccr5
11/08/2007CA2650589A1 Antisecretory protein for the treatment of compartment syndrome
11/08/2007CA2650385A1 Novel imidazole derivatives, preparation and user thereof as medicine
11/07/2007EP1852503A1 Il-13 production inhibitor
11/07/2007EP1852432A1 Nitrogenous heterocyclic compound and medicinal use thereof
11/07/2007EP1852431A1 Optically active tetrahydronaphthalene derivative
11/07/2007EP1852423A1 Crystal of 4(3h)-quinazolinone derivative
11/07/2007EP1852115A1 Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids
11/07/2007EP1850830A1 Method for production of a preparation of a solid dmso-containing silicone oil emulsion for the binding of reactive oxygen compounds in human and animal bodies
11/07/2007EP1361225B1 Compounds substituted with bicyclic amino groups
11/07/2007EP1257281B1 Nucleoside analogs with carboxamidine modified monocyclic base
11/07/2007EP1192151B1 Anilinoquinazolines as protein tyrosine kinase inhibitors
11/07/2007EP1017713B1 CYCLIC ANTAGONISTS OF C5a RECEPTORS AND G PROTEIN-COUPLED RECEPTORS
11/07/2007CN101068826A Potent LNA oligonucleotides for the inhibition of HIF-1A expression
11/07/2007CN101067134A Human Cbfal gene siRNA and its expression vector and application in preparing medicine
11/07/2007CN101066997A Human antibodies that bind human IL-12 and methods for producing
11/07/2007CN101066949A Prepn process of organic salt of coculine for diminishing inflammation and relieving pain
11/07/2007CN101066932A New conjugate linoleic acid derivative and its prepn and use
11/07/2007CN101066447A Group b streptococcus proteins, and their use
11/07/2007CN101066442A Externally applied Chinese medicine lotion for treating pain caused by wind, cold and damp
11/07/2007CN101066417A Use of Yunkang oral liquid in preparing medicine for treating menoxenia
11/07/2007CN101066411A Prepn of medicine composition of docombent corydalis rhizome
11/07/2007CN101066392A Externally applied medicine for dispelling damp, eliminating swelling and relieving pain and its prepn
11/07/2007CN101066375A Orally take Chinese medicine composition for treating rheumatoid arthritis
11/07/2007CN101066348A Medicine for treating osteoarthrosis caused by wind, cold and damp and its prepn
11/07/2007CN101066274A Prepn process of double salt potassium D-aminogluconate sulfate
11/07/2007CN101066256A Soft capsule containing common lamiophlomis root extract
11/07/2007CN101066252A Aminoglucose calcium tablet and its prepn process
11/07/2007CN100347169C 喹唑啉衍生物 Quinazoline derivatives
11/07/2007CN100347152C Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
11/07/2007CN100347151C Novel aminobenzoephenones
11/07/2007CN100346803C Tiekuaizi medicated liquor
11/07/2007CN100346779C Liquid pharmaceutical composition
11/07/2007CN100346774C Treatment agent
11/07/2007CN100346772C Devices for delivery of drugs having antiprogestinic properties
11/06/2007US7291731 7-(3-Pyridyl)-1,7-diazaspiro-[4,4]nonane and its salts and proline amides; capable of affecting nicotinic cholinergic receptors, e.g., as modulators of specific nicotinic receptor subtypes; neuroprotective agents
11/06/2007US7291709 LSR (Lipolysis Stimulated Receptor); for the prevention and/or treatment of pathologies and/or of pathogeneses such as obesity and anorexia, hyperlipidemias, atherosclerosis, diabetes, hypertension
11/06/2007US7291644 For therapy and prophylaxis of allergic disorder, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, pleuritis complicated by rheumatoid arthritis, cerebrovascular disease
11/06/2007US7291638 3-amido-1,2-benzoisoxazole derivatives, process for preparation, and use thereof
11/06/2007US7291637 4,7-Methano--, ethano-, oxy- or thio- indazol-3-ones or benzisothiazol-3-ones in which the S is mono- or dioxygenated, e.g., 3a,4,7,7a-tetrahydro-4,7-methano-1,2-benzisothiazol-3(2H)-one-1,1-dioxide; treatment of diseases such as cancer and immune disorders
11/06/2007US7291635 Protein tyrosine phosphatase 1B inhibitors alone or incombination with other antidiabetic, antilipemic, anticholesterol or hypotensive agents
11/06/2007US7291634 N-substituted-benzyl-N-(hydroxyaminocarbonylmethyl)cycloalkyl(alk)oxybenzenesulfonamides, e.g., 2-[(cyclopropylmethoxy-benzenesulfonyl)-(4-[1,2,3]triazol-1-yl-benzyl)-amino]-N-hydroxy-acetamide; treating diseases mediated by matrix-degrading metalloproteinases, in particular hyperproliferative diseases
11/06/2007US7291630 Azaindoles as inhibitors of c-Jun N-terminal kinases
11/06/2007US7291613 Inhibitors of p38 kinase
11/06/2007US7291608 Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α
11/06/2007US7291600 Non-T cell binding peptides and their uses
11/06/2007US7291451 Modulation of pericyte proliferation
11/06/2007US7291347 Solubility, permeability, and bioavailability; oral dosage
11/06/2007US7291332 Inflammatory mediator antagonists
11/06/2007US7291330 MD-1 inhibitors as immune suppressants
11/06/2007CA2388564C Caspase inhibitor
11/04/2007CA2587126A1 Method of treating inflammation disorders using extracts of passion fruit
11/02/2007CA2587002A1 Stem cells derived from bone marrow for tissue regeneration
11/01/2007WO2007124316A1 Heterocyclic compounds as inhibitors of c-fms kinase
11/01/2007WO2007123269A1 Azolecarboxamide derivative
11/01/2007WO2007123010A1 Agent for improving bone metabolism
11/01/2007WO2007122981A1 COUMARIN COMPOUND CAPABLE OF INHIBITING INDUCIBLE NITROGEN MONOOXIDE SYNTHASE (iNOS)
11/01/2007WO2007122885A1 Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator
11/01/2007WO2007122815A1 Bivalent antibody directed against bir1
11/01/2007WO2007122686A1 Benzimidazole compounds
11/01/2007WO2007121662A1 Diphenyl urea derivatives as kinase inhibitors, compositions and uses thereof
11/01/2007WO2007101988A3 Use of tsg-6 for treating bone diseases
11/01/2007WO2002090332A3 Novel aeylheteroalkylaminε derivatives
11/01/2007US20070255055 Epothilone derivatives
11/01/2007US20070254963 Ozonidzed Pharmaceutical Composition and Method
11/01/2007US20070254931 Thiazole Derivatives Having Vap-1 Inhibitory Activity
11/01/2007US20070254930 Osteoporosis drug N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl) phenoxy]pentoxy}-benzamidine (DW-1350) and an alkali metal carbonate, an alkali metal bicarbonate, or an alkaline earth metal carbonate